Juno Therapeutics ready for another round in war on cancer – Seattle Times
Seattle Times |
Juno Therapeutics ready for another round in war on cancer
Seattle Times CAR–T cell therapy for aggressive B cell Non-Hodgkin lymphoma, the form of cancer Symes had, is the most promising product in the pipeline of Seattle-based biotech company Juno Therapeutics. Many oncologists expect CAR–T cell therapies to completely … |
